Chemidoc Enterprises Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.69 M
as on 24-10-2024
- Company Age 58 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.15 M
as on 24-10-2024
- Revenue 30.98%
(FY 2023)
- Profit 2.33%
(FY 2023)
- Ebitda -15.69%
(FY 2023)
- Net Worth -0.04%
(FY 2023)
- Total Assets -18.46%
(FY 2023)
About Chemidoc Enterprises
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.69 M.
The company currently has active open charges totaling ₹1.15 M.
Praveen Kapoor, Veena Kapoor, Reeta Kapoor, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231UP1966PTC003146
- Company No.
003146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 1966
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Allahabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chemidoc Enterprises?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Kapoor  | Managing Director | 27-Nov-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Praveen Kapoor | Director | 27-Nov-2006 | Current |
| Veena Kapoor | Director | 27-Nov-2006 | Current |
| Reeta Kapoor | Director | 27-Nov-2006 | Current |
Financial Performance of Chemidoc Enterprises.
Chemidoc Enterprises Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.98% increase. The company also saw a slight improvement in profitability, with a 2.33% increase in profit. The company's net worth dipped by a decrease of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemidoc Enterprises?
In 2023, Chemidoc Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medicine Distributors Private LimitedActive 28 years 11 monthsPraveen Kapoor, Veena Kapoor and 2 more are mutual person
Adam Laboratories Private LimitedActive 32 years 9 monthsPraveen Kapoor and Pradeep Kapoor are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 Apr 1987 | ₹1.15 M | Open |
How Many Employees Work at Chemidoc Enterprises?
Unlock and access historical data on people associated with Chemidoc Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemidoc Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemidoc Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
